0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Antigen‐driven PD‐1 + TOX + BHLHE40 + and PD‐1 + TOX + EOMES + T lymphocytes regulate juvenile idiopathic arthritis in situ

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          T lymphocytes accumulate in inflamed tissues of patients with chronic inflammatory diseases (CIDs) and express pro-inflammatory cytokines upon re-stimulation in vitro. Further, a significant genetic linkage to MHC genes suggests that T lymphocytes play an important role in the pathogenesis of CIDs including juvenile idiopathic arthritis (JIA). However, the functions of T lymphocytes in established disease remain elusive. Here we dissect the transcriptional and the clonal heterogeneity of synovial T lymphocytes in JIA patients by single-cell RNA sequencing combined with T cell receptor profiling on the same cells. We identify clonally expanded subpopulations of T lymphocytes expressing genes reflecting recent activation by antigen in situ. A PD-1+ TOX+ EOMES+ population of CD4+ T lymphocytes expressed immune regulatory genes and chemoattractant genes for myeloid cells. A PD-1+ TOX+ BHLHE40+ population of CD4+ , and a mirror population of CD8+ T lymphocytes expressed genes driving inflammation, and genes supporting B lymphocyte activation in situ. This analysis points out that multiple types of T lymphocytes have to be targeted for therapeutic regeneration of tolerance in arthritis.

          Related collections

          Author and article information

          Contributors
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          Journal
          European Journal of Immunology
          Eur. J. Immunol.
          Wiley
          0014-2980
          1521-4141
          February 02 2021
          Affiliations
          [1 ]Deutsches Rheuma‐Forschungszentrum (DRFZ) Institute of the Leibniz Association Berlin Germany
          [2 ]Charité ‐ Universitätsmedizin Berlin corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin and Berlin Institute of Health Department of Nephrology and Intensive Care Medicine Berlin Germany
          [3 ]Center for Translational Immunology Wilhelmina Children's Hospital University Medical Center Utrecht Utrecht University Utrecht Netherlands
          [4 ]Department of Experimental and Clinical Medicine and DENOTHE Center University of Florence Florence Italy
          [5 ]Charité ‐ Universitätsmedizin Berlin corporate member of Freie Universität Berlin Humboldt‐Universität zu Berlin and Berlin Institute of Health Department of Pediatric Pulmonology Immunology and Critical Care Medicine Berlin Germany
          [6 ]Charité ‐ Universitätsmedizin Berlin corporate member of Freie Universität Humboldt‐Universität zu Berlin and Berlin Institute of Health Berlin SPZ (Center for Chronically Sick Children) Berlin Germany
          [7 ]Anna Meyer Children's Hospital and University of Florence Florence Italy
          [8 ]Department of Clinical Sciences and Community Health University of Milano Milano Italy
          [9 ]Department of Experimental and Clinical Medicine University of Florence Florence Italy
          [10 ]Berlin Institute of Health (BIH) Berlin Germany
          [11 ]BCRT/DRFZ Single‐Cell Laboratory for Advanced Cellular Therapies ‐ Brandenburg Center for Regenerative Therapies (BCRT) Berlin Germany
          Article
          10.1002/eji.202048797
          33296081
          00860727-7bda-4e17-81f3-0bbf87d5797f
          © 2021

          http://creativecommons.org/licenses/by-nc-nd/4.0/

          http://doi.wiley.com/10.1002/tdm_license_1.1

          History

          Comments

          Comment on this article